Selective KCa1.1 blockers significantly reduce calcium-activated chloride currents in murine portal vein myocytes, demonstrating pharmacological overlap between these channels.
No takes yet. Share an insight, caveat, or question.
Cautions against clinical extrapolation from murine data; leaves open the scope of KCa1.1-ClCa overlap in human vascular physiology.
Sones et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: